Our concern with the current state of obesity treatment is that the marketing of GLP-1 medications and their massive popularity is overshadowing scientific evidence supporting metabolic and bariatric surgery as the most efficacious therapy for obesity, lead study author Tyler Cohn, a surgeon and associate professor at Loyola University Medical Center, told Gizmodo
GHK-Cu is one of the most broadly applicable peptides in aesthetic medicine it benefits a wide range of patients
The people who see the most from it are consistently the ones who pair it with the fundamentals
Metabolic effects supported by trials: Approved semaglutide and tirzepatide regimens can improve blood-sugar control and support weight loss in eligible patients
GIP secretion increases in response to chylomicrons alone and the presence of glucose in both murine and human duodenal cultures in a dose-dependent fashion (Psichas et al., 2017)
Lets look at each of these, and then you can check your genes below in the genotype report section